varicella zoster virus (VZV)
<p>Varicella zoster virus vaccines: an update</p>
14
Seroprevalence of Antibodies against Varicella Zoster Virus among Women before Marriage in Yazd, Iran
6
Varicella-Zoster Virus-Specific Enzyme-Linked Immunospot Assay Responses and Zoster-Associated Pain in Herpes Zoster Subjects
5
Detection and Genotyping of Varicella Zoster Virus by TaqMan Allelic Discrimination Real Time PCR
5
Varicella Seroprevalence and Molecular Epidemiology of Varicella Zoster Virus in Argentina, 2002
7
ORF7 of Varicella-Zoster Virus Is a Neurotropic Factor
11
Recombination of Globally Circulating Varicella-Zoster Virus
14
Varicella zoster virus: The potentially useful virus
5
Toward Universal Varicella Zoster Virus (VZV) Genotyping: Diversity of VZV Strains from France and Spain
5
Varicella-Zoster Virus Infection in Romanian Children Infected With the Human Immunodeficiency Virus
7
Molecular Aspects of Varicella-Zoster Virus Latency
28
Labile Coat: Reason for Noninfectious Cell-free Varicella-Zoster Virus in Culture
7
Hospital Infection Control for Varicella Zoster Virus Infection
6
Varicella zoster virus associated morbidity and mortality in Africa – a systematic review
11
The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella zoster virus immunity boosting
11
Transcription mapping of the varicella-zoster virus genome.
7
Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands
13
Varicella zoster virus susceptibility and primary healthcare consultations in Norway
8
Management of Varicella Zoster Virus Infections in Prison Populations
19
Validity of Reported Varicella History as a Marker for Varicella Zoster Virus Immunity Among Unvaccinated Children, Adolescents, and Young Adults in the Post–Vaccine Licensure Era
11